AGENT FOR ACTING UPON BONE FORMATION DISTURBANCES AGENT FOR ACTING UPON BONE FORMATION DISTURBANCES CONTAINING ALKALINE CITRATES, LACTATES AND/OR MALACONTAINING ALKALINE CITRATES, LACTATES AND/OR MALATES TES

摘要

PCT No. PCT/EP95/05049 Sec. 371 Date Nov. 28, 1997 Sec. 102(e) Date Nov. 28, 1997 PCT Filed Dec. 20, 1995 PCT Pub. No. WO96/23504 PCT Pub. Date Aug. 8, 1996The invention relates to an agent for the prophylaxis and/or therapy of conditions associated with a disorder of bone formation. It contains alkali metal citrates and/or alkali metal lactates and/or alkali metal malates, optionally together with one or more active substances selected from vitamin K, calcium salts and vitamin D. The agent preferably contains potassium citrates and/or sodium citrates or potassium lactates and/or sodium lactates and serves for the prophylaxis and/or therapy of osteoclasis, in particular osteoporosis or osteomalacia.